相关实验视频
Updated: Jun 6, 2025

10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
3.5K
开发一种对过敏原的代码系统,并将其整合到HL7 FHIR过敏耐受性资源中
Yoshimasa Kawazoe1, Satomi Nagashima2, Shinichiroh Yokota3
1Artificial Intelligence and Digital Twin in Healthcare, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan.
International journal of medical informatics
|December 3, 2024
概括
开发了一种新的日本过敏原代码系统 (JFAGY),包括日本特定的过敏原,提高医疗安全和互操作性. 该系统有助于对各种过敏原进行分类,以更好地管理医疗保健数据.
科学领域:
- 医疗信息学 医疗信息学
- 过敏研究 研究过敏
- 健康数据标准 卫生数据标准
背景情况:
- 目前的过敏术语系统缺乏日本特有的过敏原,阻碍了医疗安全和数据互操作性.
- 对日本独特的过敏原进行标准化编码系统的需求对于准确的患者护理至关重要.
研究的目的:
- 为日本食品和非食品/非药物过敏原 (JFAGY) 建立一个全面的代码系统.
- 开发一个元代码系统,将JFAGY与现有的药物代码系统集成在一起.
- 为了评估JFAGY的实用性和局限性,使用HL7 FHIR过敏不耐受性概况.
主要方法:
- 过敏原术语是从日本标准商品分类,临床指南和公共文件中选择的.
- 非食品/非药物过敏原被手动编制成一个分类层次.
- 通过将12027个EHR条目映射到开发的代码中,验证了食品过敏原代码系统的覆盖范围.
主要成果:
- 该JFAGY包括1,123种食品和607种非食品/非药物过敏原术语,具有对等级关系的元代码系统.
- 绘制EHR食物过敏原图显示91.5%对应于唯一代码,1.9%对应于多个代码,6.6%未绘制.
- 一个日本的过敏不耐受性值集被开发出来,并与过敏不耐受性代码相结合.
结论:
- 该JFAGY有效地结合了日本特有的过敏原,使得等级决定和提高医疗安全.
- 与FHIR过敏不耐受资源的整合需要对拒绝过敏的FHIR扩展.
- 在日本,JFAGY系统对于改善过敏数据管理和患者安全至关重要.
相关概念视频
Allergic Reactions
27.2K
Overview
27.2K
Allergic Drug Reactions
812
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
812
Hypersensitivities
512
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
512
Cross-reactivity
31.0K
Overview
31.0K
Antibody Structure
59.0K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
59.0K
Antigens Involved in Adaptive Immunity
455
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
455

